Enterprise record
Dianthus Therapeutics, Inc.
Public governance Claims and source records for this enterprise.
Follow
More
Alpha ID: alpha:company:77633110-a488-4a3d-8965-8a6bf6fdbebaVersion: public-1As of: unavailable
11 published Claims2 sources
Key Claims
Board and committees
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026
Supports 3 claims
- Legal Name: Dianthus Therapeutics, Inc. /DE/ · Claim reviewed: Sep 28, 2026
- Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
- Published Fact: US · Claim reviewed: Sep 28, 2026
DEF 14A dnth-20260409.htm
sec proxy · Source published: Apr 9, 2026 · Retrieved: Sep 2, 2026
Supports 8 claims
- Leadership Role: Alison F. Lawton: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Anne McGeorge: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Jonathan Violin: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Marino Garcia: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Paula Soteropoulos: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Simon Read: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Steven Romano: Director · Claim reviewed: Sep 28, 2026
- Leadership Role: Sujay Kango: Director · Claim reviewed: Sep 28, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-28
- Board and committees
- published
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed

